Medical Care in the Digital Era
Electronic health records (EHRs), virtual office visits, and health-related apps are priming the path toward a future vision of medical care in the digital age. That future includes streamlining patient-provider interactions, making good use of the wealth of collected data, and ultimately improving all levels of care from prevention to diagnosis, treatment, and outcomes... Read more
The PACE of Change
At a time when a global vaccine program is being rolled out at unprecedented speed, the world is more aware than ever before of the wonders of medical science. There are, however, many diseases that remain beyond the reach of modern medicine and the potency of some of our most widely used therapies are waning... Read more
Fighting COVID-19 With Lung-Chips
The novel coronavirus is a new kind of enemy. Now, the United States Army has added a cutting-edge tool to its arsenal to better understand this threat: “organs-on-chips” that recapitulate the microarchitecture and function of living human lungs... Read more
The RADxSM Tech Process: Accelerating Innovation for COVID-19 Testing
In the wake of the COVID-19 pandemic, the need for rapid and accurate diagnostic testing across populations quickly became evident. In response, the National Institutes of Health (NIH) was determined not only to invest heavily in this area but to change the process by which grant proposals were reviewed and funded in order to spur faster development of viable technologies. The Rapid Acceleration of Diagnostics (RADx) initiative was designed to speed innovation, commercialization, and implementation of potential COVID-19 diagnostic technology... Read more
Can Coverscan Help COVID-19 Survivors?
At the start of the COVID-19 pandemic, doctors and hospitals were overburdened from patients suffering from the immediate, acute effects of the virus. But as time went on, it turned out that even the patients who survived—or had mild symptoms and didn’t require hospitalization—weren’t fully recovered... Read more
Harnessing Another Tool for Treating Brain Cancer
In the United States alone, an estimated 700,000 people have been diagnosed and are living with a brain tumor, and it is estimated that approximately 84,000 people will receive a tumor diagnosis in 2021 [1]. Fortunately, the majority of these tumors will be benign; on average only 30% of all brain tumors are malignant. For patients with malignant tumors, the current five-year survival rate is 36% with an average 31% ten-year survival rate [2], but for those diagnosed with glioblastoma (GBM)—one of the most deadly and treatment-resistant cancers—the patient survival rate falls to a low 7.2% and the median life-span after diagnosis is only eight months. GBM is the most common primary malignant brain tumor, even as an increasing numbers of cancer patients are diagnosed with brain metastases (secondary brain tumors), where the cancer has traveled to the brain from another part of the body... Read more

Pulse Ideas

Student's Corner May/June 2021
Interested in Volunteering for EMBS? Here Are Two Students’ Exciting Experiences
The IEEE Engineering in Medicine and Biology Society (EMBS) is the world’s largest international society of biomedical engineers. Volunteering for IEEE EMBS can be an enriching experience for students. We recently interviewed two exceptional EMBS volunteers to gain insight on... Read more
State of the Art May/June 2021
Innovation Is Tied to Optimism
I wonder, when this coronavirus pandemic is finally behind us, if we will have seen a pause in the technological and social progress that had been happening at such a breakneck pace before the illness had spread throughout the world. I wonder if the attention that we have been forced to place on our own survival has stolen from our ability to innovate and create. This, despite the extra time that many of us have had to endure away from our jobs and normal activities, and the time that we would now have to dream up new ­possibilities... Read more
Access more for free
EMBS
Subscribe for Pulse updates.